Test Price
750 AED✅ Home Collection Available
Spinocerebellar Ataxia Type 3 (SCA3) ATXN3 Gene Mutation Analysis in UAE – 750 AED
Executive Summary & Core Metrics
Executive Summary
Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 accredited PCR & fragment analysis (Cert: INT/EGQ/2509DA/3139).
Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
Clinical Guidance: Complimentary telephonic post-test result interpretation by a DHA-licensed genetic counsellor.
Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
This genetic test precisely quantifies the CAG trinucleotide repeat expansion in the ATXN3 gene, confirming Spinocerebellar Ataxia Type 3 (Machado‑Joseph disease) with gold‑standard fragment analysis technology. The method uses PCR amplification followed by capillary electrophoresis to determine exact repeat length.
| Feature | Our Test (ISO 9001:2015) | Typical Alternative |
|---|---|---|
| Precision (CAG Repeat Sizing) | High‑resolution capillary electrophoresis fragment analysis (±1 repeat) | Sanger sequencing – cannot accurately size large pathogenic expansions |
| Methodology | PCR + Fluorescent Fragment Length Analysis (gold standard) | Conventional PCR only (no expansion sizing) |
| Speed (TAT) | Sample by Tue 11 am → Report Saturday | Often >10 working days |
Physician Insight & Safety Protocols
“As a consultant in medical genetics, I see many patients concerned about inherited ataxias. This test provides definitive molecular confirmation of SCA3, but remember that results must always be integrated with your clinical history and family pedigree. Our genetic counsellor is here to help you understand the implications and make informed decisions.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Important Advisory
Do not discontinue any prescribed medication or start new supplements without consulting your treating physician. Abrupt changes may worsen neurological stability. Genetic findings should be discussed with a specialist before any lifestyle or therapeutic adjustments.
Safety Check: Exclusion Criteria & Emergency Red Flags
- Exclusion: Not suitable for patients who received a whole blood transfusion within the last 2 weeks (risk of donor DNA contamination).
- Exclusion: Inadequate sample volume (<2 mL) or haemolysed/clotted specimen will require recollection.
- Exclusion: Minors (under 18) must have parent/guardian consent as per Federal Decree‑Law No. 4 of 2016 on Medical Liability.
- ER Red Flag: If you experience sudden severe imbalance, dysphagia, or respiratory distress, seek emergency care immediately – these may indicate rapid disease progression unrelated to the test.
Patient FAQ & Clinical Guidance
1. What does the ATXN3 gene mutation test detect, and who should consider it?
This test precisely measures the number of CAG repeats in the ATXN3 gene to confirm spinocerebellar ataxia type 3 in patients with progressive gait imbalance, dysarthria, or a known family history of Machado‑Joseph disease. It also enables pre‑symptomatic and carrier screening after appropriate genetic counselling.
2. How should I prepare for the test, and what sample requirements must be followed?
No dietary restrictions are needed. You must complete the Genomics Clinical Information Requisition Form (Form 20) and provide a 4 mL whole blood specimen in an EDTA lavender‑top tube, kept refrigerated (never frozen). Sample collection is scheduled for Tuesday by 11 AM for Saturday reporting via our VIP mobile phlebotomy service available daily 8 AM to 11 PM.
3. Will my insurance cover the 750 AED cost, and how quickly can I receive results?
The test costs 750 AED. Our direct billing verification via WhatsApp (+971 54 548 8731) confirms your coverage within minutes. When the sample reaches our lab by Tuesday 11 AM, the report is delivered by Saturday, followed by a complimentary tele‑consultation with a DHA‑licensed genetic counsellor.
UAE Regulatory & Data Privacy Adherence
All patient data and genetic results are handled in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Informed consent for genetic testing follows the requirements of Federal Decree-Law No. 4 of 2016 on Medical Liability. Your information remains confidential and is used solely for diagnostic and clinical management purposes.
Clinical & Logistical Metadata
| Test Name | Spinocerebellar Ataxia Type 3 (SCA3) ATXN3 Gene Mutation Analysis |
| Price (AED) | 750 |
| Turnaround Time | 4–5 business days (sample collection Tuesday before 11 AM, report Saturday) |
| Sample Type / Matrix | Whole blood (EDTA lavender‑top tube) |
| Methodology Used | PCR and Fluorescent Fragment Length Analysis (Capillary Electrophoresis) |
| ICD-10-CM Code | G11.2 |
| LOINC Code | 21660-2 |
| DHA Facility License & Address | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE — DHA License: 1143 (DNA Labs UAE) |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians